Keywords
Cyclophosphamide
Premature ovarian failure
Antioxidation
Submitted : 2025-03-03
Accepted : 2025-03-18
Published : 2025-04-02
Abstract
Objective: To study the antioxidant protective effect and mechanism of melatonin on cyclophosphamide-induced premature ovarian failure model mice. Methods: Six-month sexually mature female Kunming mice were taken for one week of acclimatization and then randomly divided into a normal group, blank control group, drug control group, ovarian premature aging model group, and melatonin intervention low, medium, and high dose group, with 20 mice in each group. We observed the status and body mass of the mice in each group; observed and monitored the estrous cycle by HE staining; measured the diameter and size of the ovaries and weighed the wet weight of the ovaries; observed the morphological changes of the ovaries by HE staining and counted the developing follicles at all levels; detected the levels of serum estradiol (E2), follicle-stimulating hormone (FSH), and luteinizing hormone (LH) by ELISA; measured the levels of serum MDA, SOD, and GSH-PX by antioxidant kit; detected the levels of protein immunoblotting by ELISA; protein immunoblotting (Western blot) to examine the expression of DNA damage-related proteins γH2AX, p53, and p21 in ovarian tissues. Results: Compared with the control group, mice in the premature ovarian failure model group showed reduced mobility, rough hair, decreased body weight, disorganized estrous cycle, decreased ovarian weight (P < 0.05), decreased number of follicles at all levels of development (P < 0.05), increased number of atretic follicles (P < 0.05), significantly elevated levels of serum FSH and LH, significantly decreased levels of E2 (P < 0.05), significantly increased levels of serum MDA, significantly lower SOD and GSH-PX levels (P < 0.05), and the expression of p53, p21, and γH2AX in ovarian tissues was increased (P < 0.05). Compared with the model group of premature ovarian failure, melatonin improved the changes of the above indexes induced by cyclophosphamide-induced premature ovarian failure in mice. Conclusion: Melatonin can improve the changes of motility cycle disorders, abnormal follicular development, and abnormal serum hormone levels induced by cyclophosphamide-induced oxidative stress in mice with premature ovarian failure. At the same time, melatonin can improve the oxidative stress induced by cyclophosphamide and alleviate the role of oxidative stress-induced DNA damage in mouse ovaries by exerting its antioxidant effect.
References
Ruan X, Cheng J, Du J, et al., 2023, Application Value of Fertility Protection in the Prevention and Treatment of Premature Ovarian Insufficiency. Chinese Journal of Practical Gynecology and Obstetrics, 39(09): 913–917.
Wu J, Yu Q, 2016, Diagnosis and Treatment of Premature Ovarian Insufficiency. Chinese Medical Information Herald, 31(21): 21.
Podfigurna-Stopa A, Czyzyk A, Grymowicz M, et al., 2016, Premature Ovarian Insufficiency: The Context of Long-Term Effects. Journal of Endocrinological Investigation, 39(9): 983–990.
Shelling ML, Kirsner RS, 2010, Failure to Counsel Patients with Psoriasis to Decrease Alcohol Consumption (and Smoking). Arch Dermatol, 146(12): 667–684.
Wilson C 2011, Autoimmunity: Autoimmune Addison Disease and Premature Ovarian Failure. Nat Rev Endocrinol, 7(9): 498.
Behret H, 1999, Assessment of Existing Chemicals: A Contribution Towards Improving Chemical Safety, Gesellschaft Deutscher Chemiker, Frankfurt am Main, Germany.
Meskhi A, Seif MW, 2006, Premature Ovarian Failure. Current Opinion in Obstetrics & Gynecology, 18(04): 418–426.
Spears N, Lopes F, Stefansdottir A, et al., 2019, Ovarian Damage from Chemotherapy and Current Approaches to its Protection. Human Reproduction Update, 25(06): 673–693.
Zonta YR, Martinez M, Camargo ICC, et al., 2017, Melatonin Reduces Angiogenesis in Serous Papillary Ovarian Carcinoma of Ethanol-Preferring Rats International Journal of Molecular Sciences, 18(04): 763.
Pascuali N, Scotti L, Di Pietro M, et al., 2018, Ceramide-1-Phosphate has Protective Properties against Cyclophosphamide-Induced Ovarian Damage in a Mice Model of Premature Ovarian Failure. Human Reproduction, 33(05): 844–859.
Kovanci E, Schutt AK, 2015, Premature Ovarian Failure: Clinical Presentation and Treatment. Obstetrics and Gynecology Clinics of North America, 42(1): 153–161.
Xing CH, Wang Y, Liu JC, et al., 2022, Melatonin Reverses Mitochondria Dysfunction and Oxidative Stress-Induced Apoptosis of Sudan I-Exposed Mouse Oocytes. Ecotoxicol Environ Saf, 225: 112783.
He Q, Gu L, Lin Q, et al., 2020, The IMMP2L Mutation Causes Ovarian Aging Through ROS-Wnt/β-Catenin-Estrogen Pathway: Preventive Effects of Melatonin Endocrinology, (9): 9.
Feng J, Ma WW, Li HX, et al., 2022, Melatonin Prevents Cyclophosphamide-Induced Primordial Follicle Loss by Inhibiting Ovarian Granulosa Cell Apoptosis and Maintaining AMH Expression. Frontiers in Endocrinology, 13: 895095.
Fu X, He Z, 2008, Establishment of an Animal Model of Chemotherapy-Induced Premature Ovarian Failure. J Guangdong Medicine, (12): 1952–1954.
Zhang L, Zhang X, Zhou J, et al., 2022, Effects of Melatonin and Follicle-Stimulating Hormone on Ovarian Follicle Development and Angiogenesis in Mice. Animal Husbandry and Veterinary, 54(05): 1–8.
McLean AC, Valenzuela N, Fai S, et al., 2012, Performing Vaginal Lavage, Crystal Violet Staining, and Vaginal Cytological Evaluation for Mouse Estrous Cycle Staging Identification. Journal of Visualized Experiments: JoVE, (67): e4389.
Zhu L, Luo S, Xu L, 2008, Study on Reproductive Capacity of Mice with Immune Premature Ovarian Failure. Chinese Medical Review, (06): 13–15.
Zhang L, 2021, Effects and Mechanisms of Melatonin on Ovarian Follicle Development and Angiogenesis in Mice, thesis, Nanjing Agricultural University.
Larsen EC, Muller J, Schmiegelow K, et al., 2003, Reduced Ovarian Function in Long-Term Survivors of Radiation- and Chemotherapy-Treated Childhood Cancer. The Journal of Clinical Endocrinology and Metabolism, 88(11): 5307–5314.
Sanchez-Barcelo EJ, Mediavilla MD, Alonso-Gonzalez C, et al., 2012, Melatonin Uses in Oncology: Breast Cancer Prevention and Reduction of the Side Effects of Chemotherapy and Radiation. Expert Opinion on Investigational Drugs, 21(6): 819–831.
Vaupel P, Mayer A, 2007, Hypoxia in Cancer: Significance and Impact on Clinical Outcomes. Cancer Metastasis Reviews, 26(2): 225–239.
Talib WH, Saleh S, 2015, Propionibacterium acnes Augments Antitumor, Anti-Angiogenesis and Immunomodulatory Effects of Melatonin on Breast Cancer Implanted in Mice. PLoS One, 10(4): e0124384.
Desmeules P, Devine PJ, 2006, Characterizing the Ovotoxicity of Cyclophosphamide Metabolites on Cultured Mouse Ovaries. Toxicological Sciences: An Official Journal of the Society of Toxicology, 90(2): 500–509.
Wang S, He G, Chen M, et al., 2017, The Role of Antioxidant Enzymes in the Ovaries. Oxidative Medicine and Cellular Longevity, 2017: 4371714.
Aversa S, Pellegrino S, Barberi I, et al., Potential Utility of Melatonin as an Antioxidant During Pregnancy and in the Perinatal Period. J Matern Fetal Neonatal Med, 25(3): 207–221.
Jones RL, Pepling ME, 2013, Role of the Antiapoptotic Proteins BCL2 and MCL1 in the Neonatal Mouse Ovary. Biology of Reproduction: Offical Journal of the Society for the Study of Reproduction, 88(2): 46.
Cruz MH, Leal CL, Cruz JF, et al., 2014, Essential Actions of Melatonin in Protecting the Ovaries from Oxidative Damage. Theriogenology, 82(7): 925–932.
Matikainen T, Perez GI, Zheng TS, et al., 2001, Caspase-3 Gene Knockout Defines Cell Lineage Specificity for Programmed Cell Death Signaling in the Ovary. Endocrinology, 142(6): 2468–2480.
Feng J, 2022, The Role of Melatonin in Delaying Chemotherapy-Induced Ovarian Aging through Antioxidant, thesis, Nanchang University.
Alamro A, Al-Malky M, Ansari MGA, et al., 2022, The Effects of Melatonin and Vitamin D3 on the Gene Expression of BCl-2 and BAX in MCF-7 Breast Cancer Cell Line. Journal of King Saud University–Science, 33(2): 101287.
Fortune JE, 1994, Ovarian Follicular Growth and Development in Mammals. Biology of Reproduction, 50(2): 225–232.
Xu L, Song Y, 2003, Clinical Manifestations and Diagnostic Criteria of Premature Ovarian Failure. Journal of Practical Obstetrics and Gynecology, (04): 195–196.
Melekoglu R, Ciftci O, Eraslan S, et al., 2018, Beneficial Effects of Curcumin and Capsaicin on Cyclophosphamide-Induced Premature Ovarian Failure in a Rat Model. J Ovarian Res, 11(1): 33.
Wei T, Ling L, Feng X, et al., 2018, Effects and Mechanisms of Cyclophosphamide on the Structure and Function of Rat Ovaries. Journal of PLA Medical Journal, 43(03): 195–200.
Zhu N, Jia H, Liu X, et al., 2012, Developmental Dynamics of Mouse Follicles in Estrus Cycle and its Effect on Superovulation. Zoological Study, 33(03): 276–282.
Sun H, Wang F, Zhang P, et al., 2005, Research Progress in Monitoring Ovarian Reserve Function and Prediction of Premature Ovarian Failure. Foreign Medicine (Family Planning Volume), (05): 43–47.
Jang H, Lee OH, Lee Y, et al., 2016, Melatonin Prevents Cisplatin-Induced Primordial Follicle Loss via Suppression of PTEN/AKT/FOXO3a Pathway Activation in the Mouse Ovary. Journal of Pineal Research, 60(3): 336–347.
Zia A, Farkhondeh T, Pourbagher-Shahri AM, et al., 2021, The Role of Curcumin in Aging and Senescence: Molecular Mechanisms. Biomedicine & Pharmacotherapy, 134: 111119.
Causer AJ, Shute JK, Cummings MH, et al., 2020, Circulating Biomarkers of Antioxidant Status and Oxidative Stress in People with Cystic Fibrosis: A Systematic Review and Meta-Analysis. Redox Biology, 32: 101436.
Tan DX, Manchester LC, Terron MP, et al., 2007, One Molecule, Many Derivatives: A Never-Ending Interaction of Melatonin with Reactive Oxygen and Nitrogen Species? Journal of Pineal Research, 42(1): 28–42.
Srinivasan V, Spence DW, Pandi-Perumal SR, et al., 2008, Therapeutic Actions of Melatonin in Cancer: Possible Mechanisms. Integrative Cancer Therapies, 7(3): 189–203.
Pandi-Perumal SR, Bahammam AS, Brown GM, et al., 2013, Melatonin Antioxidative Defense: Therapeutical Implications for Aging and Neurodegenerative Processes. Neurotoxicity Research, 23(3): 267–300.
D’Adda Di Fagagna F, Reaper PM, Clay-Farrace L, et al., 2003, A DNA Damage Checkpoint Response in Telomere-Initiated Senescence. Nature, 426(6963): 194–198.
Smith SK, Kipling D, 2004, The Role of Replicative Senescence in Cancer and Human Ageing: Utility (or Otherwise) of Murine Models. Cytogenetics and Genome Research, 105(2–4): 455–463.
Ran M, Gao H, Yin J, et al., 2013, Oxidative Stress and DNA Damage. Journal of Animal Nutrition, 25(10): 2238–2245.
Abuetabh Y, Wu HH, Chai C, et al., 2022, DNA Damage Response Revisited: The p53 Family and its Regulators Provide Endless Cancer Therapy Opportunities. Experimental & Molecular Medicine, 54(10): 1658–1669.
Liu TE, Zhang L, Wang S, et al., 2015, Tripterygium Glycosides Induce Premature Ovarian Failure in Rats by Promoting p53 Phosphorylation and Activating the Serine/Threonine Kinase 11-p53-p21 Signaling Pathway. Experimental and Therapeutic Medicine, 10(1): 12–18.
Li H, 2013, Kinetics of p53 Signal Transduction Network Response to DNA Damage, thesis, Nanjing University.
El-Deiry WS, 1993, WAF1, a Potential Mediator of p53 Tumor Suppression. Cell, 75(4): 817–825.
Waldman T, Kinzler KW, Vogelstein B, 1995, p21 Is Necessary for the p53-Mediated G1 Arrest in Human Cancer Cells. Cancer Res, 55(22): 5187–5190.
Zhang X, 2018, Study on the Mechanism of Calcitonin CDH22 Regulating the Self-Renewal of Female Germ Stem Cells and the Application of Melatonin in Fertility Maintenance, Doctoral dissertation, Nanjing Agricultural University.
Wang F, 2014, Mechanism of Resveratrol and Melatonin on Oocyte Maturation and Embryonic Development, Doctoral dissertation, China Agricultural University.
Zhang M, 2024, Mechanism of Apoptosis and Autophagy Induced by Bisphenol A in Mouse Testicular Stromal Cells and the Protective Effect of Melatonin, dissertation, Nanchang University.